| Katrina Elizabeth Bradley, PHARMD | |
|
2833 Bella Vista Way, Bella Vista, AR 72714-3709 | |
| (479) 876-2153 | |
| (479) 876-2184 |
| Full Name | Katrina Elizabeth Bradley |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2833 Bella Vista Way, Bella Vista, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861979569 | NPI | - | NPPES |
| PD14611 | Other | AR | PHARMACIST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD14611 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katrina Elizabeth Bradley, PHARMD 2171 Buck Cv, Pea Ridge, AR 72751-5000 Ph: (479) 426-0614 | Katrina Elizabeth Bradley, PHARMD 2833 Bella Vista Way, Bella Vista, AR 72714-3709 Ph: (479) 876-2153 |
News Archive
Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of a larger $13 million award to the University of Washington.
There has been much recent interest in how nanotechnology will impact the field of medicine. Unfortunately, a number of promising nanostructured systems have turned out to be extremely toxic to humans, thus precluding their use in clinical applications and dashing hopes of an early success for the interdisciplinary field of nanobiotechnology.
Many gene therapy-based approaches are in development to combat genetic and other causes of blindness and vision loss, and much can be learned about the safety and effectiveness of these promising new therapies by studying them first in non-human primates before initiating clinical trials, as shown by the results of a study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
At a recent community education program, Stanford experts on women's cancer disagreed with controversial new federal guidelines on breast cancer screening. The new guidelines, released in November by the U.S. Preventive Services Task Force, would delay a woman's first mammogram by 10 years, reduce future screenings from annual to every other year, and end them after age 74.
› Verified 2 days ago
Binh Tran, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3499 Bella Vista Way, Bella Vista, AR 72714 Phone: 479-273-9136 | |
Kyle Conner, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3499 Bella Vista Way, Bella Vista, AR 72714 Phone: 479-273-9136 Fax: 479-273-9155 | |
Mrs. Robin Renee Ritter, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 408 Town Ctr Ne, Bella Vista, AR 72714 Phone: 479-855-3791 Fax: 479-876-5881 | |
Denise Avila, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3499 Bella Vista Way, Bella Vista, AR 72714 Phone: 479-273-9136 | |
Tabitha Layne Wortham, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3499 Bella Vista Way, Bella Vista, AR 72714 Phone: 479-273-9136 | |
Karen Sue Bond, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Mercy Way, Bella Vista, AR 72714 Phone: 479-876-6200 Fax: 479-876-2232 | |
Dr. Nicholas J Graham, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Mercy Way Ste 50, Bella Vista, AR 72714 Phone: 479-876-6200 |